Revisiting the continuum of pharmacist prescriptive authority
Journal of the American Pharmacists Association · 2023-09 · 63 (5) · 1508-1514
DOI: 10.1016/j.japh.2023.06.025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Pharmacists Association, 2023-09. Verfasst von Alex J Adams und 2 weiteren Autor:innen. Hauptthemen laut MEDLINE: Drug Prescriptions, Pharmacists. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 53 Literaturangaben.
Abstract (Originalsprache)
Pharmacists in all states have prescriptive authority in some form. We identify two broad categories of pharmacist prescribing: dependent and independent. There are gradients within these broad categories that allow us to chart pharmacist prescribing on a continuum from most restrictive to least restrictive. Independent prescribing has seen the most innovation in recent years at the state level, with at least three states adopting a "standard of care" prescribing framework that allows pharmacists to exercise broad prescriptive authority including for conditions that require a diagnosis. Each of the approaches to pharmacist prescriptive authority have perceived advantages and disadvantages as it relates to improving patient care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Zitieren
APA
Adams, A. J., Weaver, K. K., & Adams, J. A. (2023). Revisiting the continuum of pharmacist prescriptive authority. Journal of the American Pharmacists Association, 63(5), 1508-1514. https://doi.org/10.1016/j.japh.2023.06.025
Vancouver
Adams AJ, Weaver KK, Adams JA. Revisiting the continuum of pharmacist prescriptive authority. Journal of the American Pharmacists Association. 2023;63(5):1508-1514. doi:10.1016/j.japh.2023.06.025
BibTeX
@article{Adams2023,
author = {Adams, Alex J and Weaver, Krystalyn K and Adams, Jennifer Athay},
title = {Revisiting the continuum of pharmacist prescriptive authority},
journal = {Journal of the American Pharmacists Association},
year = {2023},
volume = {63},
number = {5},
pages = {1508--1514},
doi = {10.1016/j.japh.2023.06.025}
}
EUVIMED